Cytokine-Based Cancer Immunotherapies Summit

Temi della conferenza
This is the primary industry platform dedicated to providing you insight into the latest clinical results and stimulating discussions around
how to take cytokine-based immunotherapy combinations forward.

The renewed interest in the anti-tumor properties of cytokines has led to an increase in the number of clinical trials that explore the safety and efficacy of cytokine-based drugs, not only as single agents, but also in combination with other immunomodulatory drugs.

Professional congress organizer (PCO)
Hanson Wade

Annotazioni
Brochure: https://go.evvnt.com/708655-2?pid=4832

Speakers: Ruth Ganss, Professor in Translational Cancer Research, Harry Perkins Institute of Medical Research, University of Western Australia, and more.

https://go.evvnt.com/708655-1?pid=4832

Mr. Customer Services